Efficacy Efficacy 01:01 38% relative risk reduction in CV death with Jardiance 0:58 CV Reduction was generally consistent across baseline HbA1c 0:59 Patients could live longer with Jardiance 01:01 Relative risk reduction of CV death by more than 1/3 01:01 Early impact on risk reduction of CV death 01:01 32% Relative risk reduction in all-cause mortality 01:03 Reduction of CV death was achieved ontop of standard of care 01:01 35% Relative reduction in hospitilization for heart failure Production date: June 2020
